SpringWorks Therapeutics, Inc. (SWTX) Financials
SWTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 656.8 million | 89.4 million |
| 2023-12-31 | 725.8 million | 99.6 million |
| 2023-09-30 | 467.7 million | 72.8 million |
| 2023-06-30 | 517.3 million | 65.9 million |
SWTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -79.5 million | 30.5 million |
| 2023-12-31 | -60.4 million | 25.1 million |
| 2023-09-30 | -54.1 million | 23.1 million |
| 2023-06-30 | -50.9 million | 23.0 million |
SWTX Net Income
No data available :(
SWTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 436.6 million | - | 6.6 million |
| 2023-12-31 | 479.2 million | - | 7.1 million |
| 2023-09-30 | 422.4 million | - | 7.3 million |
| 2023-06-30 | 476.7 million | - | 7.6 million |
SWTX Shares Outstanding
SWTX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 577000 | 53.6 million | 60.1 million | 729000 |
| 2023-12-31 | 2.3 million | 43.7 million | 59.8 million | - |
| 2023-09-30 | 3.6 million | 37.5 million | 46.5 million | - |
| 2023-06-30 | 3.1 million | 35.9 million | 47.0 million | - |
SWTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 21.0 million | 1.9 million |
| 2023-12-31 | 5.4 million | 960000 |
| 2023-09-30 | 5.6 million | 933000 |
| 2023-06-30 | 5.8 million | 833000 |
SWTX
Price: $44.84
52 week price:
Earnings Per Share: -5.15 USD
P/E Ratio: -9.87
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 625779
Market Capitalization: 3.2 billion